Brown Andrew William Fraser sold $344K of P

Brown Andrew William Fraser sold 4,735 shares of Everpure, Inc. (P) at $72.57 ($0.34M total) on 2026-06-25.

Original reporting
SEC EDGAR · Brown Andrew William Fraser
Published Jun 29, 2026, 8:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 29, 2026, 9:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$P
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

It reports an open-market sale of 4,735 shares at $72.57 on 2026-06-25; no 10b5-1 plan is indicated and no other company-specific news is included.

02

Market read

Routine insider selling disclosure; unlikely to drive a fresh trading decision absent other catalysts.

03

What to watch

The transaction is small relative to typical market-moving thresholds and lacks any accompanying operational/regulatory update.

Relevance 4/10Novelty 2/10Timing: filed 2026-06-29 after-hours; sale dated 2026-06-25

Background

The article is an SEC Form 4 insider transaction disclosure for Everpure, Inc. director Andrew William Fraser.

Market effects

None—this is a routine insider Form 4 sale with no disclosed company event.

None.

None.

Counterpoint

A director sale can sometimes signal reduced confidence, but this filing provides no rationale and no 10b5-1 plan details.

Key entities

  • Everpure, Inc.

    Subject of the Form 4 insider transaction disclosure (director open-market sale).

  • Andrew William Fraser

    Director who sold 4,735 shares; holdings after sale: 27,683 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PHighAI 8/10

Everpure (P) Shares Rise After CFRA Upgrade and Strong Fiscal 20

Everpure Inc (NYSE: P) shares rose 3% after CFRA upgraded it from Sell to Buy, citing raised guidance for fiscal 2028. The company projects $7B-$7.3B in revenue and $1.7B-$1.9B in non-GAAP operating income, driven by demand for its all-flash storage solutions in AI data centers. Despite this, GuruFocus's GF Value™ suggests the stock is overvalued at $126.00, with an intrinsic value of $81.40.

$METAMedAI 8/10

Meta, Everpure, Akamai Technologies, Apimeds Pharmaceuticals and Costco: Why These 5 Stocks Are on Invest

Meta (META) rose 4.5% to $777.59, driven by AI strategy. Everpure (P) surged 11.15% to $121.88, reaffirming fiscal 2027 guidance. Akamai (AKAM) fell 6.78% to $110.41, then jumped 20.65% after-hours on a $11.6B AI deal. Apimeds (APUS) soared 114.85% to $4.92 on a blockchain agreement. Costco (COST) dipped 0.91% to $896.48 despite beating Q4 estimates.

$PHighAI 8/10

Everpure Stock Jumps As S&P 500 Inclusion Fuels Momentum

Everpure Inc. (NYSE: P) stock rose 12.77% after its inclusion in the S&P 500. The company's shares have climbed from the low-$90s to $121.88, with a high of $131.41. Everpure reported $3.66B in annual revenue, 70.2% gross margins, and a P/E above 380. The S&P 500 inclusion is expected to drive passive fund buying.

$PMed

Needham raises Everpure stock price target on strong FY28 outlook

Needham raised its price target for Everpure (NYSE:P) to $150 from $140, maintaining a Buy rating. The firm cited Everpure's strong fiscal 2028 outlook, with projected revenue growth of 39% to 45% and operating margins of 24% to 26%. The company also reported second-quarter fiscal 2027 revenue of $1.186 billion, up 38% year-over-year. Several analysts have revised earnings upwards, and the stock has returned 68.3% over the last six months.